Connect Biopharma Holdings Ltd (CNTB) stock news · rev $64.0K
Connect Biopharma Holdings Ltd (CNTB) is a biotechnology company listed on US.
This CNTB news page leads with what Connect Biopharma Holdings Ltd filed — not a scraped headline mill.
No cached 8-K sentence for CNTB yet. We will not pad this page with generic market recap.
Latest reported CNTB revenue for 2025-12-31 was $64.0K. Net income was -$55.5M. Revenue was down 99.8% from 2024-12-31 to 2025-12-31. CNTB currently screens at market cap $63.3M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the CNTB stock page; for the tape open the quote page.
CNTB stock news FAQ
What are CNTB's latest revenue and net income?
Latest cached Connect Biopharma Holdings Ltd (CNTB) revenue for Dec 31, 2025 was $64.0K. Net income was -$55.5M. Statements: https://lician.com/financials/cntb
How did CNTB revenue change from the prior cached period?
Cached Connect Biopharma Holdings Ltd (CNTB) revenue was down 99.8% from $26.0M (Dec 31, 2024) to $64.0K (Dec 31, 2025). Statements: https://lician.com/financials/cntb
What is CNTB's market cap?
Connect Biopharma Holdings Ltd (CNTB) market cap is $63.3M on the latest cached fundamentals snapshot.
What kind of company is CNTB?
Connect Biopharma Holdings Ltd (CNTB) is a biotechnology company listed on US.
Where is CNTB stock news listed?
Cached stock news for Connect Biopharma Holdings Ltd (CNTB) is listed at https://lician.com/news/cntb. Filings: https://lician.com/sec/cntb
Not investment advice.